Bob Snow/Malar J

Spatial prediction of Plasmodium falciparum prevalence in Somalia.Noor AM, Clements AC, Gething PW, Moloney G, Borle M, Shewchuk T, Hay SI, Snow RW
Malar J, (2008). 7:159

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.Wasunna B, Zurovac D, Goodman CA, Snow RW
Malar J, (2008). 7:29

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.Sipilanyambe N, Simon JL, Chanda P, Olumese P, Snow RW, Hamer DH
Malar J, (2008). 7:25

The decline in paediatric malaria admissions on the coast of Kenya.Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K, Snow RW
Malar J, (2007). 6:151

Standardizing estimates of the Plasmodium falciparum parasite rate.Smith DL, Guerra CA, Snow RW, Hay SI
Malar J, (2007). 6:131

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW
Malar J, (2007). 6:72

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW
Malar J, (2007). 6:31

Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project.Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW
Malar J, (2007). 6:17

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya.Noor AM, Omumbo JA, Amin AA, Zurovac D, Snow RW
Malar J, (2006). 5:5

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector.Amin AA, Snow RW
Malar J, (2005). 4:36

The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya.Omumbo JA, Hay SI, Guerra CA, Snow RW
Malar J, (2004). 3:17